» Articles » PMID: 36713963

Increased Myocardial Stiffness More Than Impaired Relaxation Function Limits Cardiac Performance During Exercise in Heart Failure with Preserved Ejection Fraction: a Virtual Patient Study

Abstract

Aims: The relative impact of left ventricular (LV) diastolic dysfunction (LVDD) and impaired left atrial (LA) function on cardiovascular haemodynamics in heart failure with preserved ejection fraction (HFpEF) is largely unknown. We performed virtual patient simulations to elucidate the relative effects of these factors on haemodynamics at rest and during exercise.

Methods And Results: The CircAdapt cardiovascular system model was used to simulate cardiac haemodynamics in wide ranges of impaired LV relaxation function, increased LV passive stiffness, and impaired LA function. Simulations showed that LV ejection fraction (LVEF) was preserved (>50%), despite these changes in LV and LA function. Impairment of LV relaxation function decreased / ratio and mildly increased LV filling pressure at rest. Increased LV passive stiffness resulted in increased / ratio, LA dilation and markedly elevated LV filling pressure. Impairment of LA function increased / ratio and LV filling pressure, explaining inconsistent grading of LVDD using echocardiographic indices. Exercise simulations showed that increased LV passive stiffness exerts a stronger exercise-limiting effect than impaired LV relaxation function does, especially with impaired LA function.

Conclusion: The CircAdapt model enabled realistic simulation of virtual HFpEF patients, covering a wide spectrum of LVDD and related limitations of cardiac exercise performance, all with preserved resting LVEF. Simulations suggest that increased LV passive stiffness, more than impaired relaxation function, reduces exercise tolerance, especially when LA function is impaired. In future studies, the CircAdapt model can serve as a valuable platform for patient-specific simulations to identify the disease substrate(s) underlying the individual HFpEF patient's cardiovascular phenotype.

Citing Articles

Differential Myocardial Responses in Male and Female Rats with Uremic Cardiomyopathy.

Bodi B, Vago R, Nagy L, Raduly A, Gulyas A, Kupecz K Int J Mol Sci. 2025; 26(5).

PMID: 40076880 PMC: 11900185. DOI: 10.3390/ijms26052259.


Identification of digital twins to guide interpretable AI for diagnosis and prognosis in heart failure.

Gu F, Meyer A, Jezek F, Zhang S, Catalan T, Miller A NPJ Digit Med. 2025; 8(1):110.

PMID: 39966509 PMC: 11836287. DOI: 10.1038/s41746-025-01501-9.


Accelerated atrial pacing reduces left-heart filling pressure: a combined clinical-computational study.

van Loon T, Rijks J, van Koll J, Wolffs J, Cornelussen R, van Osta N Eur Heart J. 2024; 45(46):4953-4964.

PMID: 39589540 PMC: 11631061. DOI: 10.1093/eurheartj/ehae718.


The mechanistic interaction between mechanical dyssynchrony and filling pressure in cardiac resynchronisation therapy candidates.

Beela A, Manetti C, Prinzen F, Delhaas T, Herbots L, Lumens J Eur Heart J Cardiovasc Imaging. 2024; 26(3):424-434.

PMID: 39513574 PMC: 11879185. DOI: 10.1093/ehjci/jeae286.


Management of Left Atrial Tachyrhythms in the Setting of HFpEF with Pulsed-Field Ablation: Treating Fire with Water?.

Chinyere T, Chinyere I Therapeutics (Basel). 2024; 1(1):42-51.

PMID: 39398098 PMC: 11467807. DOI: 10.3390/therapeutics1010006.


References
1.
Abudiab M, Redfield M, Melenovsky V, Olson T, Kass D, Johnson B . Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail. 2013; 15(7):776-85. PMC: 3857919. DOI: 10.1093/eurjhf/hft026. View

2.
Burkhoff D, Mirsky I, Suga H . Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol. 2005; 289(2):H501-12. DOI: 10.1152/ajpheart.00138.2005. View

3.
Lumens J, Delhaas T, Kirn B, Arts T . Three-wall segment (TriSeg) model describing mechanics and hemodynamics of ventricular interaction. Ann Biomed Eng. 2009; 37(11):2234-55. PMC: 2758607. DOI: 10.1007/s10439-009-9774-2. View

4.
Nagarakanti R, Ezekowitz M . Diastolic dysfunction and atrial fibrillation. J Interv Card Electrophysiol. 2008; 22(2):111-8. DOI: 10.1007/s10840-008-9203-8. View

5.
Roh J, Houstis N, Rosenzweig A . Why Don't We Have Proven Treatments for HFpEF?. Circ Res. 2017; 120(8):1243-1245. PMC: 5407384. DOI: 10.1161/CIRCRESAHA.116.310119. View